Search alternatives:
teer decrease » greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 40,061 - 40,080 results of 69,059 for search '(( 5 ((we decrease) OR (mean decrease)) ) OR ( 100 ((teer decrease) OR (a decrease)) ))', query time: 1.41s Refine Results
  1. 40061
    Genotype x environment interaction and genetic gain for grain yield and grain quality traits in Turkish spring wheat released between 1964 and 2010

    Genotype x environment interaction and genetic gain for grain yield and grain quality traits in Turkish spring wheat released between 1964 and 2010 by Ajit Nehe (6996812)

    Published 2019
    “…High molecular weight glutenin subunit (HMW-GS) 5+10 showed an increase in frequency whereas 2+12 showed a decrease over the breeding period.…”
    Save to List
    Saved in:
  2. 40062
    table3_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx

    table3_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:
  3. 40063
    table2_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx

    table2_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:
  4. 40064
    Data_Sheet_1_Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice.pdf

    Data_Sheet_1_Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice.... by Yuki Moritoki (706165)

    Published 2018
    “…After 16 weeks' treatment, we observed a significant reduction in portal inflammation, a decrease in liver-infiltrating mononuclear cells as well as a reduction in liver CD8<sup>+</sup> T cells. …”
    Save to List
    Saved in:
  5. 40065
    table2_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx

    table2_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:
  6. 40066
    datasheet1_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.pdf

    datasheet1_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.pdf by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:
  7. 40067
    table3_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx

    table3_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:
  8. 40068
    table1_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx

    table1_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:
  9. 40069
    table3_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx

    table3_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:
  10. 40070
    table1_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx

    table1_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:
  11. 40071
    The bioinfomatics analysis of the M1 macrophage-related gene CXCL9 signature in cervical cancer

    The bioinfomatics analysis of the M1 macrophage-related gene CXCL9 signature in cervical cancer by Wenxin Liao (18974243)

    Published 2024
    “…</p> <p>There were 77 positive coexpression genes and 5 negative coexpression genes in M1 macrophage. …”
    Save to List
    Saved in:
  12. 40072
    Table 1_Does screening mode matter? A repeated cross-sectional study of computer self-administered vs. clinician-administered screening of youth substance use in pediatric primary care.docx

    Table 1_Does screening mode matter? A repeated cross-sectional study of computer self-administered vs. clinician-administered screening of youth substance use in pediatric primary... by Chloe Gao (11107228)

    Published 2025
    “…Of the screening responses, 24.6% were from 12–13-year-olds, 29.5% from 14–15-year-olds, 28.7% from 16–17-year-olds, and 17.2% from 18–20-year-olds. …”
    Save to List
    Saved in:
  13. 40073
    table2_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx

    table2_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:
  14. 40074
    Data_Sheet_1_DHCR24 Knock-Down Induced Tau Hyperphosphorylation at Thr181, Ser199, Thr231, Ser262, Ser396 Epitopes and Inhibition of Autophagy by Overactivation of GSK3β/mTOR Signaling.pdf

    Data_Sheet_1_DHCR24 Knock-Down Induced Tau Hyperphosphorylation at Thr181, Ser199, Thr231, Ser262, Ser396 Epitopes and Inhibition of Autophagy by Overactivation of GSK3β/mTOR Signa... by Xiaojing Bai (1661731)

    Published 2021
    “…In addition, to elucidate the association between DHCR24 and tauopathy, we further showed that the level of plasma membrane cholesterol, lipid raft-anchored protein caveolin-1, and concomitantly total I class PI3-K (p110α), phospho-Akt (Thr308 and Ser473) were significantly decreased, resulting in the disruption of lipid raft/caveola and inhibition of PI3-K/Akt signaling in silencing DHCR24 SH-SY5Y cells compared to control groups. …”
    Save to List
    Saved in:
  15. 40075
    table3_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx

    table3_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:
  16. 40076
    table2_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx

    table2_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:
  17. 40077
    table1_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx

    table1_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:
  18. 40078
    datasheet1_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.pdf

    datasheet1_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.pdf by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:
  19. 40079
    table1_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx

    table1_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:
  20. 40080
    datasheet1_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.pdf

    datasheet1_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.pdf by María Sol Ruiz (9966293)

    Published 2021
    “…We detected a global decrease of microRNA levels in LSC-enriched CD34<sup>+</sup>CD38<sup>−</sup>CD26<sup>+</sup> and HSC fractions from CML-CP patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. …”
    Save to List
    Saved in:

Search Tools: